9/17
08:02 am
ipa
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.